Key Details
Last Dividend
$0.24Annual Revenue
$794.00 KAnnual EPS
-$0.26Annual ROE
-84.97%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Aug 15, 2022Recent annual earnings:
Mar 04, 2021Next ex-dividend date:
N/ARecent ex-dividend date:
Jan 13, 2023Next split:
N/ARecent split:
Oct 31, 2023Analyst ratings
Recent major analysts updates
15 Nov '21 Raymond James
Market Perform06 Aug '21 Raymond James
Outperform29 Apr '21 Raymond James
Outperform10 Feb '21 Piper Sandler
Overweight04 Feb '21 Raymond James
Outperform04 Jan '19 Oppenheimer
Outperform21 June '18 B. Riley Securities
Neutral21 June '18 B. Riley FBR
Neutral05 May '18 B. Riley FBR
Buy12 Feb '18 B. Riley Securities
BuyScreeners with CBIO included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Catalyst Biosciences?
- What is the ticker symbol for Catalyst Biosciences?
- Does Catalyst Biosciences pay dividends?
- What sector is Catalyst Biosciences in?
- What industry is Catalyst Biosciences in?
- What country is Catalyst Biosciences based in?
- When did Catalyst Biosciences go public?
- Is Catalyst Biosciences in the S&P 500?
- Is Catalyst Biosciences in the NASDAQ 100?
- Is Catalyst Biosciences in the Dow Jones?
- When was Catalyst Biosciences's last earnings report?
- When does Catalyst Biosciences report earnings?
- Should I buy Catalyst Biosciences stock now?
What is the primary business of Catalyst Biosciences?
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California.
What is the ticker symbol for Catalyst Biosciences?
The ticker symbol for Catalyst Biosciences is NASDAQ:CBIO
Does Catalyst Biosciences pay dividends?
No, Catalyst Biosciences does not pay dividends
What sector is Catalyst Biosciences in?
Catalyst Biosciences is in the Healthcare sector
What industry is Catalyst Biosciences in?
Catalyst Biosciences is in the Biotechnology industry
What country is Catalyst Biosciences based in?
Catalyst Biosciences is headquartered in United States
When did Catalyst Biosciences go public?
Catalyst Biosciences's initial public offering (IPO) was on 12 April 2006
Is Catalyst Biosciences in the S&P 500?
No, Catalyst Biosciences is not included in the S&P 500 index
Is Catalyst Biosciences in the NASDAQ 100?
No, Catalyst Biosciences is not included in the NASDAQ 100 index
Is Catalyst Biosciences in the Dow Jones?
No, Catalyst Biosciences is not included in the Dow Jones index
When was Catalyst Biosciences's last earnings report?
Catalyst Biosciences's most recent earnings report was on 15 August 2022
When does Catalyst Biosciences report earnings?
The date for Catalyst Biosciences's next earnings report has not been announced yet
Should I buy Catalyst Biosciences stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions